论文部分内容阅读
本文作者认为,除小细胞肺癌T_1N_6M_0。期外,外科手术没有价值,放疗只能缓解症状,却不能延长生存时间。尽管预防性头部放疗能否延长中位生存期还令人怀疑,但可使脑转移率降至20%以下.目前,关于小细胞肺癌的胸部放疗有许多讨论。小细胞肺癌对该治疗有高度反应性,特别是接受较大剂量照射的病人,可以推迟癌肿的复发时间。本文对28例小细胞肺癌病人的联合化疗效果进行了连续观察。化疗方案为AAA-BBB-AAA-BBB.A分别代表环磷酰胺(1000mg/m~2),阿霉素(50mg/m~2)、鬼臼乙叉甙(100mg/m~2×3次),B分别代表环磷酰胺(1000mg/m~2)、氯甲喋呤(50mg/m~2)、长春新碱(1mg/m~2×2次)。化疗
The authors of this article believe that in addition to small cell lung cancer T_1N_6M_0. Outside of surgery, surgery has no value. Radiotherapy can only relieve symptoms, but it can not prolong survival time. Although prophylactic cranial radiotherapy can be considered doubtful for a median survival period, brain metastases can be reduced to less than 20%. Currently, there is much discussion about thoracic radiotherapy for small cell lung cancer. Small cell lung cancer is highly responsive to this treatment, especially in patients receiving higher doses of radiation, which can delay the recurrence of the cancer. This article continuously observed the effect of combined chemotherapy on 28 patients with small cell lung cancer. The chemotherapy regimen for AAA-BBB-AAA-BBB.A represents cyclophosphamide (1000 mg/m~2), doxorubicin (50 mg/m~2), and etoposide (100 mg/m~2 x 3 ), B represents cyclophosphamide (1000 mg/m~2), chloromethyl purine (50 mg/m~2), vincristine (1 mg/m~2x2). Chemotherapy